SOPHIA MATOS: Open Payments
NPI 1871336628 · NEWTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$56 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $56
Food & beverage: $56
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Neuronetics, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: REXULTI, NEUROSTAR TMS THERAPY SYSTEM, UZEDY.
Industry payments across MA — which companies pay providers there.
